Patents by Inventor Hideki Kikuiri

Hideki Kikuiri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8231840
    Abstract: A suspension storage container 10 has a flat portion across a specific region including the tail end. The flat portion has an outer peripheral wall 13 forming a flat outer peripheral surface and partition walls 14 that extend in the flat cross section of the outer peripheral wall 13 in a direction substantially orthogonal to the major axis direction of the flat cross section to partition a chamber inside the outer peripheral wall 13 into plural chambers S1 through S3 aligned side by side in the major axis direction. A suspension K is stored only in part of all the chambers S1 through S3, that is, the chamber S2, and a sealing film 21 having the outline almost identical with the outline of the outer peripheral wall is laminated to the tail end surfaces of the outer peripheral wall 13 and the partition walls 14.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: July 31, 2012
    Assignee: Alfresa Pharma Corporation
    Inventor: Hideki Kikuiri
  • Patent number: 7569183
    Abstract: A fecal analyzing apparatus includes an extraction/dilution section (43) for extracting a fecal suspension from a feces sampling container (1). The fecal suspension is formed by dispersing feces in a feces-dissolving liquid in the feces sampling container (1), and mixing a diluting solution having a different concentration than the feces-dissolving liquid, with respect to a specific pigment, into the extracted fecal suspension in a predetermined amount. An optical-absorbance measurement section (61) detects the concentration of the specific pigment to be changed in response to the addition of the diluting solution, and a control device (66) determines the adequacy of the extraction amount of the fecal suspension in accordance with the detected concentration of the specific pigment. The adequacy of the extraction amount of the fecal suspension can be determined to provide an adequate assay result.
    Type: Grant
    Filed: March 28, 2005
    Date of Patent: August 4, 2009
    Assignee: Alfresa Pharma Corporation
    Inventor: Hideki Kikuiri
  • Publication number: 20080034899
    Abstract: A suspension storage container (10) has a flat portion across a specific region including the tail end. The flat portion has an outer peripheral wall (13) forming a flat outer peripheral surface and partition walls (14) that extend in the flat cross section of the outer peripheral wall (13) in a direction substantially orthogonal to the major axis direction of the flat cross section to partition a chamber inside the outer peripheral wall (13) into plural chambers (S1) through (S3) aligned side by side in the major axis direction. A suspension (K) is stored only in part of all the chambers (S1) through (S3), that is, the chamber (S2), and a sealing film 21 having the outline almost identical with the outline of the outer peripheral wall is laminated to the tail end surfaces of the outer peripheral wall (13) and the partition walls (14).
    Type: Application
    Filed: June 28, 2005
    Publication date: February 14, 2008
    Applicant: ALFRESA PHARMA CORPORATION
    Inventor: Hideki Kikuiri
  • Publication number: 20060216830
    Abstract: A fecal analyzing apparatus includes an extraction/dilution section (43) for extracting a fecal suspension from a feces sampling container (1). The fecal suspension is formed by dispersing feces in a feces-dissolving liquid in the feces sampling container (1), and mixing a diluting solution having a different concentration than the feces-dissolving liquid, with respect to a specific pigment, into the extracted fecal suspension in a predetermined amount. An optical-absorbance measurement section (61) detects the concentration of the specific pigment to be changed in response to the addition of the diluting solution, and a control device (66) determines the adequacy of the extraction amount of the fecal suspension in accordance with the detected concentration of the specific pigment. The adequacy of the extraction amount of the fecal suspension can be determined to provide an adequate assay result.
    Type: Application
    Filed: March 28, 2005
    Publication date: September 28, 2006
    Applicant: ALFRESA PHARMA CORPORATION
    Inventor: Hideki Kikuiri